Xin Lei, Longju Ma, Han Xue, Junni Wang, Liangliang Chen, Yaomin Wang et al. Intravenous daratumumab-based regimens for light-chain amyloidosis with kidney involvement: a retrospective real-world comparative study. // BMC Nephrology. – 2026. – DOI: 10.1186/s12882-026-05265-6. – URL: https://doi.org/10.1186/s12882-026-05265-6
Xin Lei, Longju Ma, Han Xue, Junni Wang, Liangliang Chen, Yaomin Wang, Lan Lan, Pingping Ren, Jianghua Chen, & Fei Han (2026). Intravenous daratumumab-based regimens for light-chain amyloidosis with kidney involvement: a retrospective real-world comparative study. BMC Nephrology. https://doi.org/10.1186/s12882-026-05265-6
Xin Lei, et al. “Intravenous daratumumab-based regimens for light-chain amyloidosis with kidney involvement: a retrospective real-world comparative study.” BMC Nephrology, 2026. doi:10.1186/s12882-026-05265-6.
@article{Lei2026,
title = {Intravenous daratumumab-based regimens for light-chain amyloidosis with kidney involvement: a retrospective real-world comparative study},
author = {Lei, Xin and Ma, Longju and Xue, Han and Wang, Junni and Chen, Liangliang and Wang, Yaomin and Lan, Lan and Ren, Pingping and Chen, Jianghua and Han, Fei},
journal = {BMC Nephrology},
year = {2026},
doi = {10.1186/s12882-026-05265-6},
url = {https://doi.org/10.1186/s12882-026-05265-6}
}